Standard Historical Balance Sheet

LAB Stock

USD 1.77 0.04 2.31%

Trend analysis of Standard Biotools balance sheet accounts such as Total Current Liabilities of 132 M provides information on Standard Biotools' total assets, liabilities, and equity, which is the actual value of Standard Biotools to its prevalent stockholders. By breaking down trends over time using Standard Biotools balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Standard Biotools latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Standard Biotools is a good buy for the upcoming year.

Standard Biotools Inventory

13.61 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.

About Standard Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Standard Biotools at a specified time, usually calculated after every quarter, six months, or one year. Standard Biotools Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Standard Biotools and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Standard currently owns. An asset can also be divided into two categories, current and non-current.

Standard Biotools Balance Sheet Chart

At present, Standard Biotools' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 132 M, whereas Total Assets are forecasted to decline to about 228.8 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Retained Earnings Total Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Standard Biotools assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Standard Biotools books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Standard Biotools balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Standard Biotools are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most accounts from Standard Biotools' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Standard Biotools current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.At present, Standard Biotools' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 132 M, whereas Total Assets are forecasted to decline to about 228.8 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	102.7M	98.2M	112.9M	104.4M
Total Assets	390.3M	323.1M	371.5M	228.8M

Short Long Term Debt Total Total Assets

Standard Biotools balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Good Will
Total Assets		0.36	0.62	0.4	0.32	0.48	0.8	0.68	-0.61	0.65	0.41	0.94	0.36	0.62	0.87	0.52	0.4	0.61	0.89	0.67	0.66	0.74	0.78	0.17	0.5	0.25
Short Long Term Debt Total	0.36		0.22	-0.17	0.19	-0.23	0.03	0.44	0.16	-0.14	0.29	0.34	0.58	0.26	0.31	-0.22	0.06	0.24	0.2	-0.03	-0.02	0.18	0.29	-0.27	-0.24	-0.17
Other Current Liab	0.62	0.22		0.8	0.67	0.59	0.58	0.35	-0.69	0.54	0.46	0.59	0.18	0.34	0.65	0.69	0.22	-0.01	0.63	0.32	0.78	0.28	0.47	0.63	0.7	0.61
Total Current Liabilities	0.4	-0.17	0.8		0.58	0.8	0.47	0.06	-0.82	0.62	0.24	0.31	-0.22	0.35	0.41	0.84	0.45	-0.19	0.55	0.32	0.81	0.18	0.43	0.96	0.85	0.84
Total Stockholder Equity	0.32	0.19	0.67	0.58		0.31	0.23	0.14	-0.35	0.46	-0.08	0.31	0.1	0.12	0.62	0.48	0.31	-0.51	0.33	0.31	0.54	-0.3	0.24	0.51	0.46	0.45
Property Plant And Equipment Net	0.48	-0.23	0.59	0.8	0.31		0.7	0.01	-0.88	0.83	0.29	0.42	-0.29	0.32	0.47	0.91	0.3	0.11	0.72	0.55	0.85	0.4	0.45	0.69	0.9	0.67
Current Deferred Revenue	0.8	0.03	0.58	0.47	0.23	0.7		0.41	-0.82	0.81	0.44	0.81	0.19	0.34	0.72	0.76	0.05	0.46	0.89	0.75	0.82	0.62	0.53	0.23	0.75	0.31
Net Debt	0.68	0.44	0.35	0.06	0.14	0.01	0.41		-0.08	0.15	-0.07	0.81	0.69	0.06	0.49	-0.01	0.11	0.54	0.52	0.35	0.15	0.57	0.2	-0.1	-0.03	-0.06
Retained Earnings	-0.61	0.16	-0.69	-0.82	-0.35	-0.88	-0.82	-0.08		-0.79	-0.45	-0.52	0.15	-0.48	-0.54	-0.95	-0.33	-0.18	-0.77	-0.57	-0.94	-0.47	-0.59	-0.68	-0.95	-0.58
Accounts Payable	0.65	-0.14	0.54	0.62	0.46	0.83	0.81	0.15	-0.79		0.18	0.59	-0.17	0.37	0.73	0.82	0.29	0.08	0.83	0.73	0.8	0.29	0.55	0.47	0.79	0.5
Cash	0.41	0.29	0.46	0.24	-0.08	0.29	0.44	-0.07	-0.45	0.18		0.26	0.0	0.57	0.28	0.33	-0.07	0.38	0.34	0.02	0.41	0.46	0.55	0.1	0.37	0.18
Non Current Assets Total	0.94	0.34	0.59	0.31	0.31	0.42	0.81	0.81	-0.52	0.59	0.26		0.49	0.34	0.82	0.45	0.18	0.59	0.85	0.67	0.59	0.7	0.53	0.06	0.43	0.14
Non Currrent Assets Other	0.36	0.58	0.18	-0.22	0.1	-0.29	0.19	0.69	0.15	-0.17	0.0	0.49		-0.1	0.35	-0.21	-0.13	0.36	0.24	0.31	-0.01	0.28	0.01	-0.37	-0.22	-0.28
Cash And Short Term Investments	0.62	0.26	0.34	0.35	0.12	0.32	0.34	0.06	-0.48	0.37	0.57	0.34	-0.1		0.47	0.37	0.73	0.4	0.49	0.27	0.42	0.52	0.97	0.3	0.36	0.32
Net Receivables	0.87	0.31	0.65	0.41	0.62	0.47	0.72	0.49	-0.54	0.73	0.28	0.82	0.35	0.47		0.55	0.33	0.25	0.79	0.77	0.67	0.39	0.66	0.19	0.52	0.27
Common Stock Shares Outstanding	0.52	-0.22	0.69	0.84	0.48	0.91	0.76	-0.01	-0.95	0.82	0.33	0.45	-0.21	0.37	0.55		0.35	0.02	0.7	0.6	0.97	0.33	0.5	0.71	1.0	0.68
Short Term Investments	0.4	0.06	0.22	0.45	0.31	0.3	0.05	0.11	-0.33	0.29	-0.07	0.18	-0.13	0.73	0.33	0.35		0.12	0.3	0.3	0.33	0.29	0.7	0.49	0.31	0.41
Non Current Liabilities Total	0.61	0.24	-0.01	-0.19	-0.51	0.11	0.46	0.54	-0.18	0.08	0.38	0.59	0.36	0.4	0.25	0.02	0.12		0.44	0.33	0.11	0.93	0.44	-0.34	0.02	-0.22
Inventory	0.89	0.2	0.63	0.55	0.33	0.72	0.89	0.52	-0.77	0.83	0.34	0.85	0.24	0.49	0.79	0.7	0.3	0.44		0.72	0.78	0.63	0.67	0.34	0.67	0.4
Other Current Assets	0.67	-0.03	0.32	0.32	0.31	0.55	0.75	0.35	-0.57	0.73	0.02	0.67	0.31	0.27	0.77	0.6	0.3	0.33	0.72		0.64	0.44	0.46	0.14	0.57	0.21
Other Stockholder Equity	0.66	-0.02	0.78	0.81	0.54	0.85	0.82	0.15	-0.94	0.8	0.41	0.59	-0.01	0.42	0.67	0.97	0.33	0.11	0.78	0.64		0.41	0.56	0.63	0.97	0.62
Total Liab	0.74	0.18	0.28	0.18	-0.3	0.4	0.62	0.57	-0.47	0.29	0.46	0.7	0.28	0.52	0.39	0.33	0.29	0.93	0.63	0.44	0.41		0.58	0.01	0.32	0.09
Total Current Assets	0.78	0.29	0.47	0.43	0.24	0.45	0.53	0.2	-0.59	0.55	0.55	0.53	0.01	0.97	0.66	0.5	0.7	0.44	0.67	0.46	0.56	0.58		0.33	0.48	0.36
Short Term Debt	0.17	-0.27	0.63	0.96	0.51	0.69	0.23	-0.1	-0.68	0.47	0.1	0.06	-0.37	0.3	0.19	0.71	0.49	-0.34	0.34	0.14	0.63	0.01	0.33		0.72	0.84
Common Stock	0.5	-0.24	0.7	0.85	0.46	0.9	0.75	-0.03	-0.95	0.79	0.37	0.43	-0.22	0.36	0.52	1.0	0.31	0.02	0.67	0.57	0.97	0.32	0.48	0.72		0.69
Good Will	0.25	-0.17	0.61	0.84	0.45	0.67	0.31	-0.06	-0.58	0.5	0.18	0.14	-0.28	0.32	0.27	0.68	0.41	-0.22	0.4	0.21	0.62	0.09	0.36	0.84	0.69

Click cells to compare fundamentals

Standard Biotools Account Relationship Matchups

Standard Biotools balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	324.8M	275.2M	390.3M	323.1M	371.5M	228.8M
Short Long Term Debt Total	95.4M	111.6M	102.7M	98.2M	112.9M	104.4M
Other Current Liab	25.6M	12.2M	10.5M	23.6M	27.2M	28.5M
Total Current Liabilities	54.2M	49.6M	43.4M	109.3M	125.7M	132.0M
Total Stockholder Equity	139.1M	94.6M	(81.5M)	163.2M	187.7M	197.1M
Property Plant And Equipment Net	55.6M	65.2M	59.5M	54.9M	63.1M	66.2M
Current Deferred Revenue	13.5M	15.5M	14.4M	11.6M	13.3M	7.8M
Net Debt	26.9M	83.2M	21.3M	46.5M	53.5M	49.6M
Retained Earnings	(676.8M)	(736.0M)	(926.1M)	(1.0B)	(900.7M)	(855.6M)
Accounts Payable	9.2M	10.6M	7.9M	9.2M	10.6M	5.5M
Cash	68.5M	28.5M	81.3M	51.7M	59.5M	43.2M
Non Current Assets Total	207.1M	203.1M	181.5M	164.9M	189.6M	124.5M
Non Currrent Assets Other	4.7M	3.7M	3.1M	2.3M	2.6M	4.4M
Cash And Short Term Investments	68.5M	28.5M	165.8M	114.9M	132.1M	72.5M
Net Receivables	25.4M	18.3M	17.3M	19.7M	22.6M	15.4M
Common Stock Shares Outstanding	72.0M	75.8M	78.3M	79.2M	91.0M	95.6M
Liabilities And Stockholders Equity	324.8M	275.2M	390.3M	323.1M	371.5M	228.8M
Non Current Liabilities Total	131.5M	131.1M	428.3M	50.5M	58.1M	55.2M
Inventory	19.7M	20.8M	21.5M	20.5M	23.6M	13.6M
Other Current Assets	4.0M	4.5M	4.3M	3.1M	3.6M	2.8M
Other Stockholder Equity	815.6M	831.4M	846.4M	854.8M	983.1M	1.0B
Total Liab	185.7M	180.6M	471.8M	159.9M	183.8M	205.2M
Total Current Assets	117.7M	72.1M	208.8M	158.2M	181.9M	104.3M
Accumulated Other Comprehensive Income	112K	(907K)	(1.9M)	(2.2M)	(2.0M)	(1.9M)
Short Term Debt	5.9M	9.9M	9.4M	63.9M	73.4M	77.1M
Common Stock	75K	77K	80K	83K	95.5K	100.2K
Good Will	106.6M	106.4M	106.3M	106.3M	122.3M	115.5M
Intangible Assets	40.2M	27.9M	12.6M	1.4M	1.3M	1.2M
Other Assets	2.6M	2.7M	2.4M	3.1M	2.8M	3.4M
Long Term Debt	54.2M	64.2M	62.8M	4.0M	3.6M	3.4M
Long Term Debt Total	53.8M	54.2M	64.2M	62.8M	56.5M	91.1M
Capital Surpluse	777.8M	815.6M	831.4M	847.0M	974.1M	774.5M
Cash And Equivalents	5.0M	20.7M	28.5M	81.3M	93.5M	98.2M
Property Plant Equipment	12.9M	55.6M	65.2M	59.5M	68.5M	36.3M
Other Liab	20.2M	39.1M	29.3M	20.2M	23.2M	28.7M
Net Tangible Assets	372K	(9.7M)	(41.0M)	110.9M	127.6M	134.0M
Net Invested Capital	193.3M	165.6M	(16.6M)	(84.5M)	(76.1M)	(72.3M)
Capital Stock	75K	77K	(81.5M)	83K	74.7K	78.4K
Non Current Liabilities Other	1.3M	882K	961K	1.1M	958.5K	888.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:

How To Invest In Standard

Details

Is Standard Stock a good investment?

Details

What is Standard Biotools' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.69)

Revenue Per Share

0.558

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.15)

Return On Equity

(0.37)

The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Standard Historical Balance Sheet

Standard Biotools Inventory

13.61 Million

About Standard Balance Sheet Analysis

Standard Biotools Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

Total Liab

Standard Biotools balance sheet Correlations

Standard Biotools Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Standard Biotools balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Shares Outstanding
Total Current Assets	+ 0.97	Cash And Short Term Investments
Other Stockholder Equity	+ 0.97	Common Stock Shares Outstanding
Common Stock	+ 0.97	Other Stockholder Equity
Short Term Debt	+ 0.96	Total Current Liabilities
Non Current Assets Total	+ 0.94	Total Assets

Common Stock	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Retained Earnings	- 0.88	Property Plant And Equipment Net
Retained Earnings	- 0.82	Current Deferred Revenue
Retained Earnings	- 0.82	Total Current Liabilities